Leukemias principles and practice of therapy

Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and expl...

Full description

Saved in:
Bibliographic Details
Other Authors: Faderl, S. H. Stefan H. (Editor), Kantarjian, Hagop 1952- (Editor)
Format: Book
Language:English
Published: Chichester, UK Wiley-Blackwell Pub. 2011
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-452276
005 2023013113415
008 230116t2011 -UK a# #001 deng D
020 # # |a 9781405182355  |q hardback 
020 # # |a 1405182350  |q hardback 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a WH 250 
090 0 0 |a WH250  |b L65597 2011 
245 0 0 |a Leukemias  |b principles and practice of therapy  |c edited by Stefan Faderl, Hagop Kantarjian 
264 # 1 |a Chichester, UK  |b Wiley-Blackwell Pub.  |c 2011 
264 # 4 |c ©2011 
300 # # |a ix, 446 pages  |b illustrations (some colour)  |c 29 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: * Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) * Ras inhibitors * Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) * Lenalidomide analogs * New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine * Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) * New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) * Thrombopoietic agents Leukemias: Principles and Practice of Therapy * Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease * Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area 
650 1 2 |a Leukemia  |x diagnosis 
650 2 2 |a Leukemia  |x therapy 
700 1 # |a Faderl, S. H.  |e editor  |q Stefan H. 
700 1 # |a Kantarjian, Hagop  |d 1952-  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=452276 
964 # # |c BOK  |d MD